Buyer for Jim Bolger co-founded bloodstock genomic testing company
Equinome, a company co-founded in 2009 by renowned Wexford horse trainer and breeder Jim Bolger has been bought by Irish equine nutrition company Plusvital which will substantially invest in the development of novel equine genomic tests, innovative nutraceuticals, and other equine performance and health products.
Jim co-founded Equinome with Dr Emmeline Hill of UCD's School of Agriculture and Food Science, as a UCD spin-out company. It is now a leader in bloodstock genomic testing. The world-class research team, led by Dr Hill, will be strengthened with the recruitment of additional highly-qualified researchers and sales and marketing staff. The combined business will employ over 35 highly qualified scientists and professionals by the end of 2017.
Plusvital provides nutrition and care products to the global equine industry.
Headquartered at UCD, Equinome works with many of the world's leading thoroughbred training and breeding operations to provide genomic information to maximise the potential success of individual racehorses.
Equinome researchers have published more scientific papers on thoroughbred exercise genomics than any other research group worldwide. Equinome has an active on research programme identifying and characterising the molecular genetic variants underlying key performance and health traits in the thoroughbred.
Brendan Cremen, UCD Director of Enterprise and Commercialisation said that Equinome has already achieved global impact, reach and sales and significantly changed breeding techniques in the international multi-billion euro thoroughbred horse racing and breeding industry.